BioMarin Pharmaceutical | BMRN - 당기 순이익

주가
54.21
매일 변경
0.91 1.71%
매월
-1.06%
매년
-14.88%
Q2 예상
52.04




당기 순이익 변화 날짜
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Insmed USD -328.48M 41.54M 2025-12
Ionis Pharmaceuticals USD -93M 136M 2026-03
Moderna USD -200M 625M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
PTC Therapeutics USD -134.96M 150.86M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
United Therapeutics USD 364.3M 25.6M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12